Our tofacitinib intermediate is also known as cis-1-benzyl-4-methyl-3-methylaminopiperidine dihydrochloride and has CAS number 1062580-52-2. The intermediate is a key ingredient in the production of tofacitinib, a drug used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. As key intermediates in the synthesis of tofacitinib, our products are vital to pharmaceutical researchers and manufacturers. This intermediate compound is carefully synthesized to ensure the highest level of purity and consistency. With our state-of-the-art manufacturing processes and stringent quality control measures, you can trust that our tofacitinib intermediates meet the highest industry standards for purity and stability. Tofacitinib Intermediate (3R, 4R) -1-Benzyl-3- (Mmethylamino) -4-Mmethylpiperidine DiHClide has a wide range of applications, making it a valuable asset in pharmaceutical and chemical research. Whether you are conducting academic research or developing pharmaceuticals, our intermediate compounds provide reliable and cost-effective solutions to your specific needs.JDK owns the first-class production facilities and Quality management equipments, which assures the stable supply of API intermediates. Professional team assure R&D of the product. Against both, we are searching for CMO & CDMO in domestic and international market.